Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 11:26 AM ET


Company Overview of Triax Pharmaceuticals, LLC

Company Overview

Triax Pharmaceuticals, LLC, a specialty pharmaceutical company, engages in the development, sale, and marketing of dermatological products in the United States. It offers creams, ointments, solutions, and lotions; Minocin kit, an adjunctive therapy in the treatment of severe acne; calming wipes, serums, and masques; and minocycline for injection. The company also provides pellet-filled capsules, foaming cleansers, moisturizers, and tretinoin creams, as well as patient assistance programs. The company was founded in 2004 and is based in Cranford, New Jersey. As of April 30, 2012, Triax Pharmaceuticals, LLC operates as a subsidiary of Onset Dermatologics LLC.

11 Commerce Drive

First Floor

Cranford, NJ 07016-3599

United States

Founded in 2004





Key Executives for Triax Pharmaceuticals, LLC

Senior Vice President of Regulatory Affairs and Operations
Senior Vice President
Age: 60
Vice President of Trade and Managed Markets
Vice President of Sales
Age: 54
Compensation as of Fiscal Year 2015.

Triax Pharmaceuticals, LLC Key Developments

Glenmark Generics Inc. Files Lawsuit Against Astellas Pharma Europe B.V, Astellas International, Triax Pharmaceuticals, LLC, Precision Dermatology, Inc, Onset Dermatologics, LLC and Metacon Labs

Glenmark Generics Inc. has filed a lawsuit in the court of chancery of the state of Delaware against Astellas Pharma Europe B.V, Astellas International, Triax Pharmaceuticals, LLC, Precision Dermatology, Inc, Onset Dermatologics, LLC and Metacon Labs. The lawsuit seeks to enforce Glenmark's exclusive royalty-bearing license agreement with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV. Under that agreement, Glenmark is entitled to 180 days of exclusivity with respect to its Hydrocortisone Butyrate Cream, as it is the first generic company to file an abbreviated new drug application (ANDA) for the product.

Similar Private Companies By Industry

Company Name Region
MedPodium Health Products, Inc. United States
Zurex Pharma, Inc. United States
Cebix Incorporated United States
Drug Royalty LLC United States
A-FAM LLC Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Triax Pharmaceuticals, LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at